Volume 28, Number 3—March 2022
Dispatch
Effects of COVID-19 Pandemic Response on Service Provision for Sexually Transmitted Infections, HIV, and Viral Hepatitis, England
Holly D. Mitchell
, Tatiana Garcia Vilaplana, Sema Mandal, Natasha Ratna, Megan Glancy, Ammi Shah, Ruth Simmons, Celia Penman, Freja Kirsebom, Annastella Costella, Alison E. Brown, Hamish Mohammed, Valerie Delpech, Katy Sinka1, Gwenda Hughes1, and on behalf of the UK Health Security Agency National STI, HIV and Viral Hepatitis Surveillance Group2
, Tatiana Garcia Vilaplana, Sema Mandal, Natasha Ratna, Megan Glancy, Ammi Shah, Ruth Simmons, Celia Penman, Freja Kirsebom, Annastella Costella, Alison E. Brown, Hamish Mohammed, Valerie Delpech, Katy Sinka1, Gwenda Hughes1, and on behalf of the UK Health Security Agency National STI, HIV and Viral Hepatitis Surveillance Group2
Figure 2
Figure 2. Hepatitis C virus treatment initiations, England, January 2019–September 2020. Data are from the National Health Service England Hepatitis C Patient Registry and Treatment Outcome system. Bars indicate the number of persons having treatment initiated by month for 2019 (light green) and 2020 (dark green).
1These senior authors contributed equally to this article.
2Additional group members who contributed are listed at the end of this article.
Page created: January 12, 2022
Page updated: February 21, 2022
Page reviewed: February 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.